OrCam device

OrCam device refers to the assistive-technology product brand developed by OrCam Technologies Ltd., an Israeli company founded in Jerusalem in 2010 by Professor Amnon Shashua and Ziv Aviram. The founders had previously established Mobileye, the computer-vision company later acquired by Intel. OrCam was created to apply artificial intelligence, miniature cameras, image processing and speech output to accessibility problems, initially concentrating on blindness and low vision. The brand became best known for OrCam MyEye, a compact camera-based wearable that attached magnetically to eyeglass frames. Pointed toward printed material, a person, a barcode, currency or another visual target, the device could process the information and communicate results through a small speaker or connected earpiece. Its central proposition was to make visual information available through hearing without requiring the user to hold a smartphone. Depending on the model and software, functions included reading printed and digital text, recognizing faces, identifying products and barcodes, recognizing currency and assisting with basic navigation of everyday information. The company emphasized that early devices did not continuously record sound or images, distinguishing them from more conspicuous consumer wearables and addressing some privacy concerns associated with products such as Google Glass. OrCam began developing the technology after its 2010 founding, launched the first MyEye commercially in 2015 and expanded the range through products such as OrCam MyReader and the smaller MyEye 2.0, introduced in 2017. MyEye 2.0 weighed approximately 22.5 grams and was designed to clip onto many eyeglass frames. The product line received accessibility and consumer-electronics recognition and was introduced through rehabilitation and blindness organizations in the United States, including programs associated with the California Department of Rehabilitation and the Chicago Lighthouse. The company experienced a period of rapid financing and valuation growth. It raised venture and institutional capital, reached a reported valuation of about $1 billion in 2018 and raised additional money in 2021 while considering a public offering. That offering did not occur. OrCam later faced a combination of weakening technology-market conditions, reduced demand in some markets, the effects of the Israel–Hamas war and accelerating generative-AI capabilities in smartphones. These developments reduced the distinctiveness and commercial prospects of dedicated visual-reading hardware. Between late 2022 and 2024, OrCam undertook several layoffs and closed the development division responsible for its low-vision reading products. The company said that advances in image processing and language models made continued development of those products unnecessary. By 2025, the organization had contracted to fewer than 50 employees and had shifted its principal attention to hearing assistance under the OrCam Hear name. OrCam Hear combines earbuds, a smartphone-connected device and an application that identifies and enhances a selected speaker in noisy environments. The technology is intended to address the conversational “cocktail party” problem by creating voice profiles and emphasizing the chosen speaker. Thus, OrCam’s brand history spans two distinct phases: a pioneering wearable-vision phase centered on MyEye and MyReader, followed by a restructuring and pivot toward AI-enhanced hearing. The brand remains associated with accessible computing and assistive artificial intelligence, although its former vision products have been discontinued and its long-term commercial position has become uncertain.

OrCam Technologies was established in Jerusalem in 2010 by Amnon Shashua and Ziv Aviram, who had previously co-founded Mobileye. The new company focused on assistive applications of computer vision rather than automotive driver assistance. Its objective was to allow people who were blind or had low vision to obtain information from their surroundings through a small, wearable camera and spoken output. After several years of engineering, testing and product development, OrCam introduced its first commercial MyEye device in 2015. The product attached to eyeglasses and used computer-vision algorithms to recognize and read text, identify faces and objects, and interpret barcodes and currency. Unlike a general-purpose smartphone, it was designed as a dedicated, relatively discreet accessibility tool that could be operated through gestures or simple controls. The information was delivered acoustically, allowing a user to keep both hands available. The company expanded internationally and developed related products, including MyReader for text-reading applications and MyEye 2.0, which debuted in December 2017. OrCam promoted the products through accessibility organizations, rehabilitation programs and consumer-electronics channels. Its technology supported multiple languages, including English, French, German, Hebrew and Spanish, with additional European languages added over time. Recognition from organizations and trade shows helped establish the brand in the accessibility sector. OrCam’s growth was accompanied by substantial private financing. Intel Capital participated in early funding, and Intel’s cumulative investment had reached a reported $15 million by 2014. By 2017, the company had reportedly raised $41 million and was valued at approximately $600 million. A further 2018 financing round brought the reported valuation to about $1 billion. During the pandemic period, OrCam considered a public listing and reported ambitions for a valuation above $2.5 billion after a 2021 financing round. The proposed IPO did not materialize. The business later encountered structural pressure. Smartphones increasingly incorporated optical character recognition, object recognition and generative-AI services that could perform functions resembling those of dedicated reading devices. At the same time, OrCam faced weaker sales in some Arab markets, disruption associated with the Israel–Hamas war and a broader contraction in technology spending. The company began layoffs in late 2022, including a reduction of 62 employees in October, while Elad Serfaty replaced Rani Hagag as chief executive and initiated a reorganization. Further reductions occurred in February and June 2024. The June cuts primarily affected marketing roles supporting the reading-glasses business in Israel and the United States. In July, OrCam announced that it was ending development of its low-vision product division, explaining that progress in image processing and language models had reduced the need for additional dedicated products. The MyEye and related visual-assistance lines were consequently discontinued. OrCam then concentrated on hearing technology. OrCam Hear combines earbuds, a smartphone dongle or connected device and a mobile application. The system samples speakers, creates voice profiles and attempts to enhance the selected person in a noisy environment. This addresses the well-known difficulty of following one conversation among several simultaneous voices, often called the cocktail-party problem. By early 2025, the company had reportedly declined to fewer than 50 employees and was seeking to preserve its operations. A financing dispute between the founders and institutional investors concerned the conversion terms of a founder-backed SAFE investment made at a much lower prospective valuation than earlier funding rounds. The founders also sought additional financing while pursuing a broader fundraising plan. OrCam’s current identity therefore rests on a smaller hearing-assistance business, while its earlier MyEye brand remains its most recognized contribution to wearable accessibility technology.

• 2025

  Financing dispute and reduced scale

  [1]OrCam deviceen.wikipedia.org

  The founders and institutional investors dispute the terms of a proposed SAFE conversion as the company operates with fewer than 50 employees.

• 2024

  Vision-product division is closed

  [1]OrCam deviceen.wikipedia.org

  After several rounds of workforce reductions, OrCam discontinues development of its low-vision reading products and pivots toward hearing assistance.

• 2022

  Leadership transition and first major layoffs

  [1]OrCam deviceen.wikipedia.org

  Elad Serfaty succeeds Rani Hagag as chief executive, and the company cuts 62 positions during a reorganization.

• 2021

  IPO ambitions intensify

  [1]OrCam deviceen.wikipedia.org

  OrCam raises a further financing round and considers a New York public offering, but the listing does not proceed.

• 2018

  Company reaches reported billion-dollar valuation

  [1]OrCam deviceen.wikipedia.org

  A new financing round led by Israeli institutional investors reportedly valued OrCam at approximately $1 billion.

• 2017

  MyEye 2.0 is introduced

  [1]OrCam deviceen.wikipedia.org

  The smaller MyEye 2.0 expands the wearable product family and adds versions with broader recognition features.

• 2015

  First commercial MyEye sales

  [1]OrCam deviceen.wikipedia.org

  OrCam begins commercial sales of its camera-based wearable reader for people with visual impairments.

• 2013

  MyEye development reaches launch stage

  [1]OrCam deviceen.wikipedia.org

  The company launches its wearable artificial-vision technology after development and testing.

• 2010

  OrCam is founded

  [1]OrCam deviceen.wikipedia.org

  Amnon Shashua and Ziv Aviram establish OrCam Technologies in Jerusalem to develop AI-based assistive technology.

Assistive technology that uses artificial intelligence to make visual or auditory information easier to access, initially through discreet wearable vision devices and later through AI-assisted hearing products.

• Wearable artificial-vision device · 2015

  OrCam MyEye

  A small camera-based device that attaches to eyeglass frames and uses computer vision and speech output to read text, recognize faces, identify objects and interpret selected barcodes or currency. It was designed primarily for people who are blind or have low vision and delivered information privately through audio rather than a visual display.

• Wearable artificial-vision device · 2017

  OrCam MyEye 2.0

  A compact, battery-powered generation of the MyEye platform introduced in 2017. Weighing approximately 22.5 grams, it attached magnetically to eyeglass frames and was offered in configurations ranging from text reading to broader face, barcode and object recognition.

• Portable reading aid

  OrCam MyReader

  A vision-assistance product in the OrCam family focused on converting printed text into spoken information. It addressed users who needed reading support and formed part of the company’s earlier low-vision portfolio.

• AI hearing-assistance system · 2024

  OrCam Hear

  A hearing-assistance system consisting of earbuds, a smartphone-connected component and a mobile application. It uses voice-enhancement and speaker-separation techniques to create profiles of selected speakers and emphasize them in noisy environments.

• 2018New York introduction program

  United States

  A team led by New York Assemblyman Dov Hikind introduced OrCam devices to ten screened individuals to demonstrate their potential benefits.

  Outcome. The program raised local awareness of wearable reading and recognition technology.

  Source
• 2016California Department of Rehabilitation program

  United States

  OrCam reached an arrangement with California’s Department of Rehabilitation that enabled eligible blind and visually impaired residents to qualify for its devices.

  Outcome. The arrangement expanded access through a public rehabilitation system.

  Source
• 2016Chicago Lighthouse demonstrations

  United States

  The Chicago Lighthouse demonstrated OrCam technology as part of its work supporting people with visual impairments.

  Outcome. The demonstration provided an institutional setting for evaluating the device’s accessibility applications.

  Source

• 2025

  Contest proposed SAFE conversion termsOther

  Background

  Institutional investors challenged the proposed conversion of founder-provided SAFE financing at a valuation far below earlier financing valuations.

  Action taken

  The founders and company opposed the investors’ position and sought further financing, including a proposed loan to maintain operations.

  Aftermath

  The dispute contributed to uncertainty around ownership dilution and the company’s ability to secure additional capital.

  Founder SAFE financing and proposed conversion valuation. Approximately $9 million invested by founders; earlier company valuations had reached hundreds of millions to approximately $1.5 billion → Proposed conversion valuation of approximately $30–40 million (Approximately eight months before the 2025 dispute and subsequent financing discussions)

  Source

• 2024

  End visual-assistance development and pivot to hearingStrategy

  Background

  Smartphone image processing and generative-AI systems increasingly performed functions similar to dedicated visual readers, while OrCam faced weaker sales and workforce reductions.

  Action taken

  OrCam closed its low-vision product-development division, discontinued its vision-related products and redirected resources toward OrCam Hear.

  Aftermath

  The company became substantially smaller and focused its remaining business on AI-assisted hearing technology.

  Source

1. 1OrCam deviceen.wikipedia.org